Post-Surgery Recovery Stack

The Post-Surgery Recovery Stack is a targeted tissue repair protocol engineered to accelerate healing timelines following surgical procedures. This intermediate-level stack combines three peptides with complementary mechanisms that address wound healing, inflammation management, and tissue remodeling simultaneously. BPC-157, administered at 500mcg twice daily, forms the foundation of this recovery protocol. This 15-amino-acid peptide, originally isolated from human gastric juice, has demonstrated remarkable wound-healing properties in numerous preclinical studies. It accelerates angiogenesis, promotes fibroblast migration to wound sites, and upregulates growth factor receptors including VEGF and EGF. The twice-daily dosing maintains consistent tissue-level concentrations throughout the healing process, supporting continuous repair signaling around the clock. TB-500, dosed at 5000mcg twice weekly, provides the structural scaffolding for tissue regeneration. As a synthetic fragment of Thymosin Beta-4, it promotes cellular migration by upregulating actin polymerization, allowing repair cells to reach damaged tissue more efficiently. TB-500 also reduces scar tissue formation by modulating inflammatory cytokines during the proliferative phase of wound healing, resulting in more functional tissue restoration rather than fibrotic repair. GHK-Cu at 200mcg daily rounds out the stack with its powerful tissue-remodeling properties. This copper-binding tripeptide stimulates collagen synthesis, attracts immune cells for debris clearance, and promotes nerve regeneration. Research has shown GHK-Cu activates over 4,000 genes involved in tissue repair and remodeling, making it an exceptionally broad-spectrum healing agent. This stack is ideal for individuals recovering from orthopedic surgeries, cosmetic procedures, or any operation involving significant tissue disruption. It is recommended to begin the protocol 3-5 days post-surgery once initial hemostasis is established. BPC-157 injections are most effective when administered near the surgical site subcutaneously. A typical cycle runs 6-8 weeks, aligning with standard surgical recovery windows. Bloodwork monitoring is recommended but not strictly required at this intermediate level.